Sign up Australia
Proactive Investors - Run By Investors For Investors

WeedMD signs deal to supply Ontario Cannabis Store

The deal is the fifth supply agreement agreed by the firm, it said
WeedMD signs deal to supply Ontario Cannabis Store
Weedmd is a federally-licenced producer and distributor of cannabis and cannabis oil

Cannabis producer WeedMD Inc (CVE:WMD) has signed another supply deal - this time for its home province of Ontario.

It has agreed with Ontario Cannabis Retail Corp (OCRC), operating as the Ontario Cannabis Store (OCS), to supply branded cannabis products to the adult-use market in the province.

The deal is the fifth supply agreement agreed by the firm.

In addition to Ontario, it has also signed agreements with the Alberta Gaming, Liquor & Cannabis Commission (AGLC), the British Columbia Liquor Distribution Branch (BC LDB), the Nova Scotia Liquor Corporation (NSLC) and Shoppers Drug Mart.

"As a leading Ontario licenced producer, we're thrilled to announce that adult consumers in our home province will have access to our trusted, medical-grade cannabis strains and products this fall," said Keith Merker, chief executive of WeedMD.

Milestone

"This counts as a significant milestone for WeedMD as it advances our strategic plan to develop a national distribution network at optimal price points to ensure the company's medical and adult-use products are available from coast-to-coast."

Yesterday, WeedMD told investors that Michael Pesner has joined the board as an independent director, while Bruce Dawson-Scully was stepping down.

Pesner will also become chair of the audit committee. He is an accountant and president of Hermitage Canada Finance Inc, specialising in financial and capital markets advisory services since 2002.

WeedMD shares added 0.49% to C$2.05.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Newswire
August 31 2018

Related Articles

cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
Kaneh Bosom Biotechnology: experienced management, access to capital and a clear strategy paves the
August 14 2018
The company says access to capital and a clear strategy will help it succeed

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use